31 New Inn Yard
+44 203 928 2814
C/ de Bailèn
998 Bloor Street West
ON M6H 1L8
FDA set to launch widespread CBD testing plan to tackle product inconsistencies
Earlier this month, the US FDA released data on the US CBD market as part of a review by the White House relating to cannabis and CBD research.
Our weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry.